Skip to main content
Clinical Trials/NCT05726136
NCT05726136
Recruiting
Phase 4

Comparison of Albumin and Ringer's Solution for Optimization of the Plasma Volume and Hemodynamics During Laparoscopic Surgery.

Joachim Zdolsek1 site in 1 country60 target enrollmentOctober 23, 2023

Overview

Phase
Phase 4
Intervention
acetated Ringers
Conditions
Colorectal Cancer
Sponsor
Joachim Zdolsek
Enrollment
60
Locations
1
Primary Endpoint
Plasma volume expansion after a fluid bolus
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.

Detailed Description

60 patients scheduled for laparoscopic abdominal surgery, with a duration exceeding 90 minutes will be included in the study. These are randomized to three different groups (20 in each groups): The first group of patients will receive boluses of acetated Ringers 4 ml/kg body weight. The second albumin 4 ml/kg body weight and the third group albumin 20% 1 ml/kg body weight. Hemoglobin, albumin and colloid osmotic pressure (COP) is sampled the day before surgery and in the morning directly prior to the anesthesia. Bioimpedance, urine osmolality and urine-creatinin are also measured. After induction of surgery a Cardio Q probe is inserted threw the nose into the esophagus, for circulatory measurements. Initial/baseline blood samples are taken after insufflation of carbon dioxide to the abdomen. Before every bolus of fluid and 5, (10), 15, 20, 30, 40, (50) and (60) minutes new blood samples are taken for determination of hemoglobin, albumin and COP. Artery blood gases are sampled 15 minutes after every infusion or depending on the clinical need.

Registry
clinicaltrials.gov
Start Date
October 23, 2023
End Date
October 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Joachim Zdolsek
Responsible Party
Sponsor Investigator
Principal Investigator

Joachim Zdolsek

consultant, assoc prof

University Hospital, Linkoeping

Eligibility Criteria

Inclusion Criteria

  • Written consent to participate in the study
  • For women: relevant contraceptive, menopausal or a negative pregnancy test.
  • ASA category I to III
  • Laparoscopic abdominal surgery, with a duration of at least 90 minutes.
  • 18 to 80 years

Exclusion Criteria

  • Patients with known cardiac failure
  • \<18 or \>80 years
  • known allergy to albumin
  • extracellular hyperhydration or hypervolemia
  • kidney failure
  • pregnancy or planned pregnancy

Arms & Interventions

acetated Ringers

The circulatory effect of a bolus infusion with 4 ml/kg body weight of acetated Ringers will be studied. If cardiac output increase with 10% a second bolus will be infused and further studied.

Intervention: acetated Ringers

albumin 5%

The circulatory effect of a bolus infusion with 4 ml/kg body weight of Albumin 5% will be studied. If cardiac output increases with 10% a second bolus will be infused and further studied.

Intervention: albumin 5%

albumin 20%

The circulatory effect of a bolus infusion with 1 ml/kg body weight of Albumin 20% will be studied. If cardiac output increase with 10% a second bolus will be infused and further studied.

Intervention: albumin 20%

Outcomes

Primary Outcomes

Plasma volume expansion after a fluid bolus

Time Frame: 60 minutes after an intravenous fluid bolus

Plasma volume using hemoglobin as an indicator of dilution

Secondary Outcomes

  • Stroke Volume(60 minutes after an intravenous fluid bolus)
  • Arterial Blood Pressure(60 minutes after an intravenous fluid bolus)
  • Heart Rate(60 minutes after an intravenous fluid bolus)
  • Bioimpedance(18 to 24 hours)
  • arterial serum sodium(60 minutes after an intravenous fluid bolus)
  • Fluid Balance(18 to 24 hours)
  • Serum Creatinin(18 to 24 hours)
  • arterial pH(60 minutes after an intravenous fluid bolus)
  • arterial Base Excess(60 minutes after an intravenous fluid bolus)
  • arterial serum chloride(60 minutes after an intravenous fluid bolus)

Study Sites (1)

Loading locations...

Similar Trials